Cipher Pharmaceuticals (TSE:CPH) Stock Price Passes Below 50 Day Moving Average – Should You Sell?

Cipher Pharmaceuticals Inc. (TSE:CPH) (NASDAQ:CPHR) crossed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of C$14.70 and traded as low as C$14.70. Cipher Pharmaceuticals shares last traded at C$14.80, with a volume of 19,351 shares.

Cipher Pharmaceuticals Stock Performance

The stock has a market capitalization of C$375.48 million, a price-to-earnings ratio of 22.09 and a beta of 1.02. The company has a 50 day simple moving average of C$14.70 and a 200-day simple moving average of C$14.59. The company has a quick ratio of 2.67, a current ratio of 2.00 and a debt-to-equity ratio of 41.22.

Cipher Pharmaceuticals (TSE:CPH) (NASDAQ:CPHR) last announced its quarterly earnings data on Thursday, November 6th. The company reported C$0.21 EPS for the quarter. The company had revenue of C$17.87 million during the quarter. Cipher Pharmaceuticals had a net margin of 59.92% and a return on equity of 17.93%. As a group, equities research analysts expect that Cipher Pharmaceuticals Inc. will post 1.2907348 EPS for the current fiscal year.

Cipher Pharmaceuticals Company Profile

Cipher Pharmaceuticals (TSX: CPH) (OTCQX: CPHRF) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products, mainly in dermatology. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products in Canada, the U.S., and South America.